APA (7e ed.) Bronvermelding

Fernandez-Mercado, M., Pellagatti, A., Di Genua, C., Larrayoz, M., Winkelmann, N., Aranaz, P., . . . Boultwood, J. (2013). Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

Chicago (17e ed.) Bronvermelding

Fernandez-Mercado, M., et al. Mutations in SETBP1 Are Recurrent in Myelodysplastic Syndromes and Often Coexist with Cytogenetic Markers Associated with Disease Progression. 2013.

MLA (9e ed.) Bronvermelding

Fernandez-Mercado, M., et al. Mutations in SETBP1 Are Recurrent in Myelodysplastic Syndromes and Often Coexist with Cytogenetic Markers Associated with Disease Progression. 2013.